日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Immunohistochemical Evaluation of Cathepsin B, L, and S Expression in Breast Cancer Patients

乳腺癌患者组织蛋白酶 B、L 和 S 表达的免疫组织化学评估

Daan G J Linders, Okker D Bijlstra, Laura C Fallert, N Geeske Dekker-Ensink, Taryn L March, Martin Pool, Ethan Walker, Brian Straight, James P Basilion, Matthew Bogyo, Jacobus Burggraaf, Denise E Hilling, Alexander L Vahrmeijer, Peter J K Kuppen, A Stijn L P Crobach2

89Zr-PET imaging to predict tumor uptake of 177Lu-NNV003 anti-CD37 radioimmunotherapy in mouse models of B cell lymphoma

89Zr-PET 成像预测小鼠 B 细胞淋巴瘤模型中 177Lu-NNV003 抗 CD37 放射免疫疗法的肿瘤摄取

Danique Giesen, Marjolijn N Lub-de Hooge, Marcel Nijland, Helen Heyerdahl, Jostein Dahle, Elisabeth G E de Vries, Martin Pool

89Zr-Onartuzumab PET imaging of c-MET receptor dynamics

89Zr-Onartuzumab PET 成像 c-MET 受体动力学

Martin Pool, Anton G T Terwisscha van Scheltinga, Arjan Kol, Danique Giesen, Elisabeth G E de Vries, Marjolijn N Lub-de Hooge

89Zr-mAb3481 PET for HER3 tumor status assessment during lapatinib treatment

89Zr-mAb3481 PET 用于拉帕替尼治疗期间 HER3 肿瘤状态评估

Martin Pool, Arjan Kol, Steven de Jong, Elisabeth G E de Vries, Marjolijn N Lub-de Hooge, Anton G T Terwisscha van Scheltinga

ADCC responses and blocking of EGFR-mediated signaling and cell growth by combining the anti-EGFR antibodies imgatuzumab and cetuximab in NSCLC cells

通过在 NSCLC 细胞中联合使用抗 EGFR 抗体 imgatuzumab 和西妥昔单抗来促进 ADCC 反应并阻断 EGFR 介导的信号传导和细胞生长

Arjan Kol, Anton Terwisscha van Scheltinga, Martin Pool, Christian Gerdes, Elisabeth de Vries, Steven de Jong